Cargando…

US Growth Hormone Use in the Idiopathic Short Stature Era: Trends in Insurer Payments and Patient Financial Burden

OBJECTIVE: To investigate trends in prevalence and expenditures of growth hormone (GH) use by US youth in the last 15 years, a period during which the US Food and Drug Administration (FDA) approved GH treatment of idiopathic short stature (ISS), and insurers imposed greater barriers to GH treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimberg, Adda, Kanter, Genevieve P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795021/ https://www.ncbi.nlm.nih.gov/pubmed/31637343 http://dx.doi.org/10.1210/js.2019-00246

Ejemplares similares

SUN-249 Growth Hormone Utilization By US Youth: Trends as Insurance Pushes Back after FDA-Approved Expansion
por: Grimberg, Adda, et al.
Publicado: (2019)

Evaluation of craniofacial morphology in short-statured children: growth hormone deficiency versus idiopathic short stature
por: Kim, Ki Bong, et al.
Publicado: (2020)

Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency
por: Kim, Seul Ah, et al.
Publicado: (2014)

Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency
por: Im, Minji, et al.
Publicado: (2017)

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
por: Kanter, Genevieve P., et al.
Publicado: (2019)

Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature
por: Benabbad, Imane, et al.
Publicado: (2018)

Is Universal Health Insurance Superior in Terms of Healthcare Payment? Estimating Financial Burden of Healthcare in Korea: 2009 to 2019
por: Lee, Changwoo
Publicado: (2022)

Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency
por: Yoon, Ju Young, et al.
Publicado: (2022)

Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short Stature
por: Kim, Ho-Seong, et al.
Publicado: (2014)

Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population
por: Dillon, Paul, et al.
Publicado: (2018)

The financial burden of out of pocket payments on medicines among households in Ethiopia: analysis of trends and contributing factors
por: Mekuria, Getahun Asmamaw, et al.
Publicado: (2023)

Gender Bias in U.S. Pediatric Growth Hormone Treatment
por: Grimberg, Adda, et al.
Publicado: (2015)

Development of a predictive model of growth hormone deficiency and idiopathic short stature in children
por: Cong, Mengdi, et al.
Publicado: (2021)

Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
por: Chae, Hyun Wook, et al.
Publicado: (2022)

Idiopathic Short Stature: Conundrums of Definition and Treatment
por: Rosenbloom, Arlan L.
Publicado: (2009)

Novel genetic cause of idiopathic short stature
por: Kang, Min Jae
Publicado: (2017)

Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and Insulin-like Growth Factor-I Z-scores
por: Oberle, Megan, et al.
Publicado: (2017)

SUN-LB17 The Association of Growth Hormone Treatment in Children With Short Stature With Idiopathic Scoliosis
por: Nam, Hyo-Kyoung, et al.
Publicado: (2020)

Differentially methylated CpGs in response to growth hormone administration in children with idiopathic short stature
por: Shao, Xiaojian, et al.
Publicado: (2022)

A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency
por: Gou, Peng, et al.
Publicado: (2022)

Trends in total hospital financial performance under the prospective payment system
por: Fisher, Charles R.
Publicado: (1992)

OR07-6 Integrating Targeted Bioinformatic Searches of the Electronic Health Records and Genomic Testing Identifies a Molecular Diagnosis in Three Patients with Undiagnosed Short Stature
por: Cabrera Salcedo, Catalina, et al.
Publicado: (2019)

Controversies in the Definition and Treatment of Idiopathic Short Stature (ISS)
por: Pedicelli, Stefania, et al.
Publicado: (2009)

Heterozygous NPR2 Variants in Idiopathic Short Stature
por: Stavber, Lana, et al.
Publicado: (2022)

A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature
por: Hellgren, Gunnel, et al.
Publicado: (2008)

Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2011)

Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit
por: Sotos, Juan F, et al.
Publicado: (2014)

Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature
por: Dias, Christel, et al.
Publicado: (2017)

SAT-105 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: El-Naghy, Zeyad, et al.
Publicado: (2020)

Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature
por: Han, Wenbiao, et al.
Publicado: (2022)

PMON331 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: Krasnow, Matthew, et al.
Publicado: (2022)

Association between uric acid and height during growth hormone therapy in children with idiopathic short stature
por: Yoon, Jong Seo, et al.
Publicado: (2022)

Prevalence of Short Stature and Growth Hormone Deficiency and Factors Associated With Short Stature After Fontan Surgery
por: Matsumura, Shun, et al.
Publicado: (2020)

Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height
por: Ariza-Jimenez, Ana-Belen, et al.
Publicado: (2021)

Historical trends in health care-related financial holdings among members of Congress
por: McCoy, Matthew S., et al.
Publicado: (2021)

The Rationale for Growth Hormone Therapy in Children with Short Stature
por: Deodati, Annalisa, et al.
Publicado: (2017)

Growth hormone therapy response in children with short stature
por: Gad, Amira Ahmed, et al.
Publicado: (2023)

A Radiomics-Based Model with the Potential to Differentiate Growth Hormone Deficiency and Idiopathic Short Stature on Sella MRI
por: Lee, Taeyoun, et al.
Publicado: (2022)

PMON330 The Relationship between Pituitary Volume and Chiari Malformation in Growth Hormone Deficiency and Idiopathic Short Stature
por: Manely, Sarah, et al.
Publicado: (2022)

Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency
por: Alzahrani, Ali K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ubr3dvib933439cf48um0a1m70